Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.

Launched by UNIVERSITY OF CALGARY · Mar 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a method called the Transversus Abdominis Plane (TAP) block to see if it helps reduce pain for women undergoing a cesarean section (C-section). The TAP block is a type of nerve block where a doctor injects a long-lasting numbing medicine into the abdominal wall at the end of the surgery. Previous studies suggest that this technique may lower the need for stronger pain medications, allowing patients to move around more easily after surgery and possibly spend less time in the hospital.

Women aged 18 and older who are scheduled for an elective C-section and are in generally good health may be eligible to participate in this trial. However, those with certain conditions, such as allergies to local anesthetics or chronic pain issues, will not be included. If you decide to join the trial, you can expect to receive the TAP block as part of your care, and researchers will monitor your pain levels and recovery experience to gather important information about how well this approach works.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • ASA status II to III
• • All patients undergoing elective CS under regional anesthesia at any gestational age.
• Exclusion Criteria:
• • - Known drug allergy to local anesthetics
• • Planned general anesthetic
• • NSAID use contraindicated post partum
• • Chronic pain disorder or chronic narcotic use/dependence
• • Planned vertical abdominal incision
• • Planned Cesarean Hysterectomy.
• • Placenta Previa or suspected Placenta Accreta